Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holweg

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Transplantation|April 13, 1999
Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantationC C Baan, C J Knoop, T van Gelder, et al.
Thorax|April 4, 2019
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label studyJohn Busby, Cecile T J Holweg, Akiko Chai, et al.
Regenerative Biomaterials|January 23, 2023
Degradation behavior and osseointegration of Mg-Zn-Ca screws in different bone regions of growing sheep: a pilot studyRomy Marek, Hanna Ćwieka, Nicholas Donohue, et al.
Journal of Lipid Research|June 29, 2017
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmaticsAmisha V Barochia, Elizabeth M Gordon, Maryann Kaler, et al.
BJS Open|June 8, 2026
Liver mobilization during Kasai portoenterostomy: retrospective multicentre analysisMarie Uecker, Maximilian Holweg, Maria Hukkinen, et al.
Science Translational Medicine|September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritisKasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Respiratory Research|June 9, 2018
Serum periostin does not reflect type 2-driven inflammation in COPDO A Carpaij, F O W Muntinghe, M B Wagenaar, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Transplantation|April 13, 1999
Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantationC C Baan, C J Knoop, T van Gelder, et al.
Thorax|April 4, 2019
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label studyJohn Busby, Cecile T J Holweg, Akiko Chai, et al.
Regenerative Biomaterials|January 23, 2023
Degradation behavior and osseointegration of Mg-Zn-Ca screws in different bone regions of growing sheep: a pilot studyRomy Marek, Hanna Ćwieka, Nicholas Donohue, et al.
Journal of Lipid Research|June 29, 2017
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmaticsAmisha V Barochia, Elizabeth M Gordon, Maryann Kaler, et al.
BJS Open|June 8, 2026
Liver mobilization during Kasai portoenterostomy: retrospective multicentre analysisMarie Uecker, Maximilian Holweg, Maria Hukkinen, et al.
Science Translational Medicine|September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritisKasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Respiratory Research|June 9, 2018
Serum periostin does not reflect type 2-driven inflammation in COPDO A Carpaij, F O W Muntinghe, M B Wagenaar, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
Pageof 16